GlassScriptPhysician profile
Diana L Tzeng
NPI 1821288408
$11,692.36
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.21 · 2020: $50.05 · 2021: $3,860 · 2022: $41.48 · 2023: $1,200 · 2024: $6,530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Travel and Lodging: $3,032 · Food and Beverage: $698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Travel and Lodging | $3,031.98 |
| Food and Beverage | $697.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,255.25 | 2020-2024 | Amplatzer Talisman, Amplatzer Amulet |
| Astrazeneca Pharmaceuticals LP | $1,860.00 | 2021 | |
| Medtronic, INC. | $248.03 | 2022-2023 | Mycarelink |
| Boston Scientific Corporation | $174.81 | 2023 | Watchman Flx |
| W. L. Gore & Associates, INC. | $124.60 | 2024 | Gore Cardioform Septal Occluder |
| Philips North America LLC | $18.46 | 2022 | |
| Genentech USA, INC. | $11.21 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Tzeng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.